Bertók L, Takáts A, Chen H, Cook J A
Frédéric Joliot-Curie National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary.
Acta Microbiol Immunol Hung. 1995;42(4):409-18.
Endotoxin (LPS) tolerance produces changes in macrophage mediator production which is thought to be responsible for the acquired LPS resistance. Detoxification of LPS by gamma irradiation has been reported to diminish certain noxious properties while retaining its tolerance inducing actions. We compared the efficacy of LPS and radiodetoxified (RD)-LPS from Escherichia coli O101 on stimulating rat peritoneal macrophage arachidonic acid (AA) metabolism, measured by thromboxane (TXB2). Changes in macrophage production of these mediators were also assessed after tolerance induction. LPS tolerance was induced by i.p. injection of LPS, RD-LPS or vehicle on day 1 (100 micrograms/kg, i.p.) and day 2 (500 micrograms/kg, i.p.). On day 5 or 4 weeks after pretreatment, peritoneal macrophages were harvested for in vitro studies, or rats were tested for lethality resistance. Macrophages were incubated +/- LPS (0.1 ng to 50 micrograms/ml), lipid A (1 or 10 micrograms/ml) or Ca+2 ionophore A23187 (10 microM) for determination of TXB2 production. Minimum effective concentrations of LPS and RD-LPS for stimulation (P < 0.05) of TXB2 were 100 ng/ml and 1 microgram/ml, respectively. Maximal stimulation of TXB2 occurred at 10 micrograms/ml of LPS or RD-LPS. Macrophages from LPS or RD-LPS tolerized rats were refractory to stimulated TXB2 with LPS or RD-LPS (0.1 ng to 50 micrograms/ml). The suppressed in vitro macrophage TXB2 production was apparent 4 weeks after rats were tolerized with LPS or RD-LPS. In subsequent mortality studies, LPS challenge of control or tolerance rats at day 5 in vivo with Salmonella enteritidis LPS (15 mg/kg, i.v.) produced a 90% mortality in control rats (N = 22), versus 13% mortality in the LPS pretreated group (N = 23) and a 20% in the RD-LPS pretreated group (N = 10) (P < 0.05 vs control). However, this lethality resistance was not apparent at 4 weeks after LPS or RD-LPS pretreatment. Both LPS and RD-LPS appear to be equipotent in inducing macrophage alterations, and in lethality resistance during LPS tolerance induction. However, these observations suggest that during LPS tolerance suppression of LPS-stimulated AA in peritoneal macrophage metabolism persists longer than acquired lethality resistance.
内毒素(脂多糖,LPS)耐受会导致巨噬细胞介质产生发生变化,这种变化被认为是获得性LPS抗性的原因。据报道,通过γ射线辐照对LPS进行解毒可减少某些有害特性,同时保留其诱导耐受的作用。我们比较了来自大肠杆菌O101的LPS和经辐射解毒(RD)的LPS对刺激大鼠腹腔巨噬细胞花生四烯酸(AA)代谢的效果,通过血栓素(TXB2)进行测定。在诱导耐受后,还评估了这些介质在巨噬细胞中的产生变化。于第1天(100微克/千克,腹腔注射)和第2天(500微克/千克,腹腔注射)通过腹腔注射LPS、RD-LPS或赋形剂诱导LPS耐受。在预处理后第5天或4周,收获腹腔巨噬细胞用于体外研究,或对大鼠进行致死抗性测试。将巨噬细胞与LPS(0.1纳克至50微克/毫升)、脂多糖(1或10微克/毫升)或钙离子载体A23187(10微摩尔)一起孵育,以测定TXB2的产生。刺激TXB2产生(P<0.05)的LPS和RD-LPS的最低有效浓度分别为100纳克/毫升和1微克/毫升。TXB2的最大刺激发生在10微克/毫升的LPS或RD-LPS时。来自LPS或RD-LPS耐受大鼠的巨噬细胞对LPS或RD-LPS(0.1纳克至50微克/毫升)刺激的TXB2不敏感。在用LPS或RD-LPS使大鼠耐受后4周,体外巨噬细胞TXB2产生的抑制作用明显。在随后的死亡率研究中,于第5天用肠炎沙门氏菌LPS(15毫克/千克,静脉注射)对对照或耐受大鼠进行LPS攻击,对照大鼠(N = 22)的死亡率为90%,而LPS预处理组(N = 23)的死亡率为13%,RD-LPS预处理组(N = 10)的死亡率为20%(与对照相比,P<0.05)。然而,在LPS或RD-LPS预处理后4周,这种致死抗性并不明显。LPS和RD-LPS在诱导巨噬细胞改变以及LPS耐受诱导期间的致死抗性方面似乎具有同等效力。然而,这些观察结果表明,在LPS耐受期间,腹腔巨噬细胞代谢中LPS刺激的AA的抑制持续时间比获得性致死抗性更长。